HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.

Abstract
4'-thio-beta-D-arabinofuranosylcytosine (T-araC) exhibits excellent in vivo antitumor activity against a variety of solid tumors despite its structural similarity to beta-D-arabinofuranosylcytosine (araC), an agent which is poorly active against solid tumors in vivo. It is of great interest to elucidate why these compounds show a profound difference in antitumor activity. Because deoxycytidine kinase (dCK) is the critical enzyme in the activation of both compounds, here we report the differences in the substrate characteristics with human dCK between these compounds. The catalytic efficiency (V(max)/K(m)) of araC was 100-fold higher than that of T-araC using either ATP or UTP as the phosphate donor. However, V(max) values of araC and T-araC were similar when UTP was the phosphate donor. Since UTP is believed to be the true phosphate donor for dCK in intact cells, these data indicated that the rates of phosphorylation of these two compounds at high pharmacologically relevant concentrations would be similar. This prediction was confirmed in intact cell experiments, which supported the hypothesis that UTP is the physiological phosphate donor for dCK phosphorylation in cells. The relative lack of importance of phosphate donor to the phosphorylation of T-araC by dCK revealed important insights into the activation of this compound in human cells at pharmacological doses. These studies indicated that replacement of the 4'-oxygen with sulfur significantly reduced the substrate activity of nucleoside analogs with dCK and that the superior activity of T-araC with respect to araC against solid tumors was not due to superior activity with dCK.
AuthorsHitoshi Someya, Sue C Shaddix, Kamal N Tiwari, John A Secrist 3rd, William B Parker
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 304 Issue 3 Pg. 1314-22 (Mar 2003) ISSN: 0022-3565 [Print] United States
PMID12604712 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Arabinonucleosides
  • Cell Extracts
  • Cytarabine
  • Deoxycytidine
  • Adenosine Triphosphate
  • Deoxycytidine Kinase
  • Phosphoric Monoester Hydrolases
  • Uridine Triphosphate
  • 4'-thio-arabinofuranosylcytosine
Topics
  • Adenosine Triphosphate (metabolism)
  • Arabinonucleosides (metabolism, pharmacology)
  • Cell Division (drug effects)
  • Cell Extracts
  • Cytarabine (metabolism, pharmacology)
  • Deoxycytidine (metabolism, pharmacology)
  • Deoxycytidine Kinase (metabolism)
  • Humans
  • Phosphoric Monoester Hydrolases (metabolism)
  • Phosphorylation
  • Tumor Cells, Cultured
  • Uridine Triphosphate (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: